|
Ali Andalibi
VP Research and CSO
Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center
former Program Director SBIR/STTR National Cancer Institute, NIH
NCET2 Activities: 100S: Research Commercialization Introductory Course
BIO:
Dr. Ali Andalibi is a Program Director and head of the Therapeutics and Diagnostics Cluster in the National Cancer Institute’s SBIR Development Center. Dr. Andalibi received his PhD from the UCLA department of Microbiology and Molecular Genetics and later joined the faculty in the UCLA department of Medicine. Subsequently, he was involved in several early stage biotechnology companies. He then joined the House Ear Institute (HEI) as Director of New Technology and Project Development and held a joint appointment in the Department of Otolaryngology at the University of Southern California, School of Medicine. Prior to moving to the NCI, Dr. Andalibi served as a Program Director in the National Science Foundation’s Division of Industrial Innovation and Partnerships, where he oversaw the NSF’s medical biotechnology SBIR/STTR grant portfolio.
|
